Home|Journals|Articles by Year

Directory for Medical Articles

Research Article

EEO. 2021; 20(5): 3938-3941

Covid-19 Vaccination in Pakistan: Challenges and Priorities

Muhmmad Umair Sohail, Hina Munir, Obaid Aslam, Khizar Hayat.


Most under-developed countries are facing the problem of low economic growth and receive limited financial assistance programs for the economical year 2020-2021. They are unable to provide the basic hygienic facilities, clean water and to control climate changes. It's a very difficult task for low-income countries to produce or manage the COVID-19 vaccine due to limited research and financial infrastructure. The government of Pakistan is still struggling to control polio and other genetically transferred diseases, but this commination disease creates another medical problem all over the country. Recently, collaboration was engaged between Pak-China medical research institutions to facilitate the community as much as possible. From various control group studies, the government starts the vaccination of frontline paramedical staff to keep their life secure. But the question is that is it possible for the government to manage 220 million doses with high poverty rate, low economic growth, immature behavior of religious scholars, and high police pressure from the opposition parties. The objective of this study is to provide a framework by elaborate on their challenges and priorities. Due to limited workforce and financial support, large burden of early communication and placebo diseases, the current pandemic is demanding a comprehensive framework to control the speedy spreadness of COVID-19 and quick health and economic recovery.

Key words: Communication diseases, COVID-19, Low economic growth, Poverty level, Vaccination

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.